Evolution of the degrees of influenza vaccine (flu shot) coverage in Spain throughout the 1993-2001 period. Analysis by autonomous communities;Evolución de las coberturas vacunales antigripales entre 1993-2001 en España. Análisis por comunidades autónomas

Revista Espanola de Salud Publica

Volumn 78, Issue 4, 2004, Pages 481-492

  Mayo Montero, Elga ^a   Hernández Barrera, Valentín ^a   Sierra Moros, Ma José ^b   Del Amo, Isabel Pachón ^b   Carrasco Garrido, Pilar ^a   De Miguel, Ángel Gil ^a   Jiménez García, Rodrigo ^a,c  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^c Facultad de Ciencias de la Salud   (Spain)

Author keywords

Health Surveys; Immunizations Coverage; Influenza

Indexed keywords

FLU SHOT; INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SPAIN;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; SPAIN; VACCINATION;

EID: 3442888550     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Influenza: Report by the WHO Secretariat, World Health Assembly - May 2003 http://www.who.int/gb/EB_WHA/PDF/WHA56/ea5623.pdf
2. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20(13-14):1831-6.
3. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003;21:1769-1775
4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR 2004;53:[1-40].
5. Costa Tadeo X, Navarro Aznarez G, Campos Abellana C, Esporrin Bosque C, Romero Ruiz AI. Evaluacion del no cumplimiento de un programa de vacunación antigripal. Aten Primaria. 1991; 8(7):544-6.
6. Generalidad de Cataluña. Departamento de Sanidad y Seguridad Social. Dirección General de Salud Pública. Guía técnica de la vacuna antigripal Campaña 2003-2004. http://www.gencat.net/sanitat/depsan/units/sanitat/pdf/esguiavagripcas.pdf.
7. Van Essen G.A, Palache A.M., Forleo, D.S. Fedson. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785.
8. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults:A randomized controlled trial. JAMA 2000; 284:1661-5
9. T.M. Govaert; C. T. Thijs; N. Masurel, M. J. Sprenger; G. J. Dinant; J. A. Knottnerus.The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.JAMA 1994;272:166-5.
10. Guerin N. Assessing immunization coverage: how and why'? Vaccine 1998;16;Suppl:S81-3.
11. LeBaron CW, Chaney M, Baughman AL, Dini EF, Maes E, Dietz V, Bernier R. Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA 1997; 277(8):631-35.
12. Kroneman M, Paget WJ, van Essen GA. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill. 2003 Jun;8(6):130-8.
13. Ambrosch F, Fedson D Influenza vaccination in 29 countries. An update to 1997. Pharmaeconomics 1999;16(Supl 1):47-54.
14. Navarro JA, Bernal Gonzalez PJ. Calendarios, coberturas vacunales y enfermedades inmunoprevenibles en países de Europa Occidental. Vacunas 2003;4:188-194.
15. Jimenez R, Larrauri A, Carrasco P, Esteban J, Gomez-Lopez LI, Gil A. Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years. Vaccine. 2003 Sep 8;21(25-26):3550-5.
16. Sarriá A; Timoner J. Determinantes de la vacunación de la gripe en personas mayores de 65 años. REv Esp Salud Pública 2002;76:17-26.
17. Batalla J, Urbitzondo L, Martinez M, Batista JM, Parrón I; Taberner, Salleras LI. La cobertura de la vacunación antigripal en Cataluña. Vacunas 2001; 2:130-134.
18. Domínguez A, Juncá R, Tresserres, J, Batalla J, Salleras L. Influenza vaccination: the prevalence of risk factors in persons aged 60 years and more in Catalonia Vacunas 2003;4:114-8.
19. Puig-Barberá J; Ors Zarzoso P; Vilches Peña C; Lloria Paes F; Impacto de las distintas estrategias en las tasas de vacunación antigripal en ancianos. At Primaria 1996;6:339-345.
20. Russell ML. Denominators for estimation of influenza vaccine coverage among high risk persons aged 15 to 64 years. Can J Public Health 1996;87(5):301-4.
21. Pleis JR, Gentleman JF. Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults. Eff Clin Pract. 2002 May-Jun;5(3 Suppl):E3
22. Nelson DE, Powell-Griner E, Town M, Kovar MG.A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003 Aug;93(8):1335-41.
23. Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza.and pneumonia immunization rates. J Am Pharm Assoc (Wash DC). 2003 May-Jun;43(3):403-11
24. Singleton JA, Greby SM, Wooten KG, Walker FJ, Strikas R. Influenza, pneumococcal and tetanus toxioid vaccination of adults - United States, 1993-7.MMWR CDC Surveill Summ. 2000 Sep 22;49(9):39-62.
25. Janes GR, Blackman DK, Bolen JC, Kamimoto LA, Rhodes L, Caplan LS, et al. Surveillance for use of preventive health-care services by older adults, 1995-1997. MMWR CDC Surveill Summ. 1999 Dec 17;48(8):51-88.
26. Ford ES, Mannino DM, Willíams SG. Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest. 2003 Sep;124(3):783-9.
27. Ministerio de Sanidad y Consumo, Subdirección General de Epidemiología, Promoción y Educación para la Salud. Encuesta Nacional de Salud de España 1993 [Spanish National Health Survey 1993] Madrid (Spain), 1995.
28. Ministerio de Sanidad y Consumo, Subdirección General de Epidemiología, Promoción y Educación para la Salud. Encuesta Nacional de Salud de España 2001 [Spanish National Health Survey 2001] Madrid (Spain), 2003.
29. Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of sel-reported of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16(3):67-72.
30. Hutchinson BG. Measurement of influenza vaccination status of the elderly by mailed questionnaire:response rate, validity and cost. Can J Public 1989;80(4):271-5.
31. Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003 Mar 28;21(13-14):1486-91.
32. Centers for the Disease Control and Prevention. Prevention and control of influenza recommendations of the Advisory Committee on Immnization Practices. MMWR Morb Mortal Wkly Rep 2000;49(RR-3):6.
33. CDC. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or =65 years - United States, 1989-2001 MMWR Morb Mortal Wkly Rep. 2003 Oct 10;52(40):958-62.
34. CDC. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years - United States, 2001, MMWR Morb Mortal Wkly Rep. 2002;5:1019-24.
35. Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine. 1997; 15(3):317-20.